• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee

Research review

Do "GLP-1 supplements" work? What the research does and doesn't show

Berberine, fiber and probiotic strains marketed as "GLP-1 supplements" each have preclinical or small human data touching GLP-1, but the human weight evidence is mixed to null and none has been shown to match a prescription GLP-1 medicine.

By Electric Tiger Editorial

The evidence doesn't support any over-the-counter "GLP-1 supplement" raising this gut hormone enough to match a prescription GLP-1 medicine. Berberine, soluble fiber and specific probiotic strains have each been studied for an effect on GLP-1, but the human trials are small, mixed, and none has shown the weight change a GLP-1 medicine produces.

What the evidence doesn't support

It doesn't support the idea behind the "GLP-1 supplement" category: there is no over-the-counter ingredient with human trial evidence that it raises GLP-1 enough to produce the appetite and weight effects associated with prescription GLP-1 medicines. "GLP-1 supplement" isn't a regulatory or medical term — it's a label attached to existing ingredients, mostly berberine, fiber blends and probiotic strains, because each has some published research, largely in cells or animals, touching on this hormone. It also doesn't support using any of these products as a substitute for a prescription GLP-1 medicine, or as a way to get a prescription medicine's effect without one.

What the trials found

Berberine has the most mechanistic research behind the "GLP-1" label. A 2010 study found that berberine increased GLP-1 secretion in rats after a glucose load and promoted growth of the intestinal cells that release it, and stimulated GLP-1 release in a human intestinal cell line (NCI-H716) in the lab. A 2015 follow-up traced part of that effect to a bitter-taste receptor pathway in gut cells. Both are preclinical — animal and cell-culture findings, not evidence that swallowing a berberine capsule raises GLP-1 in a person. A 2021 review lists several other food-derived compounds studied the same way, including tea, curcumin, cinnamon, wheat, soybean, resveratrol and gardenia, which is the broader (and equally preclinical) evidence base the "GLP-1 supplement" label draws on.

What berberine has been tested for directly in humans is body weight, not GLP-1 itself, and the results disagree. A 2020 meta-analysis of 10 randomized trials found no significant change in body weight (−0.11 kg, p=0.79), though BMI and waist circumference fell slightly. A second 2020 meta-analysis of 12 trials in 849 people also found no significant change in body weight, BMI or waist circumference, though waist-to-hip ratio fell slightly. A third 2020 meta-analysis, also pooling 12 trials, found the opposite: a significant average reduction in body weight of 2.07 kg, plus lower BMI, waist circumference and C-reactive protein. The three reviews drew on different, overlapping sets of small trials, and none is a large or high-quality dataset on its own — the honest read is that the human weight evidence for berberine is inconsistent, not that it has been shown to work the way a GLP-1 medicine does.

Fiber's link to GLP-1 has more human testing, but most of it is short and inconsistent. A 2026 scoping review pooled 52 studies (1,085 participants in total, a median of just 19 people per study) testing whether specific dietary fibers raise circulating GLP-1 and satiety; most were single-meal, acute experiments in Western populations. Dextrin-type fibers showed the most consistent effect on both GLP-1 and satiety among the fiber types studied, but results varied widely by fiber type, and a rise in GLP-1 didn't reliably come with a rise in reported fullness. A 2020 randomized trial of a soluble fiber dextrin, given at breakfast and again as a snack, found no effect on GLP-1, ghrelin, CCK or PYY — the other gut hormones involved in appetite — and no effect on subjective appetite or how much people ate for the rest of the day.

Probiotics have the least human data of the three. One randomized, placebo-controlled trial gave 65 adults with obesity a single strain, Bifidobacterium breve BBr60, at 10 billion CFU a day for 12 weeks, alongside standard dietary counseling for both groups. GLP-1 and several other metabolic hormones rose in the probiotic group and didn't change in the placebo group, and insulin resistance improved. It's one trial of one strain at one dose — it doesn't establish that "probiotics" as a category, or any other strain sold under a "GLP-1 supplement" label, does the same thing.

Ingredient Human GLP-1 evidence Human weight/appetite evidence
Berberine None — GLP-1 effect shown only in rats and cultured cells Mixed: 2 of 3 meta-analyses found no significant change in body weight
Fiber (dextrin-type) Inconsistent across small, mostly single-meal trials One randomized trial found no effect on appetite hormones or food intake
Probiotics (single strain) Rose in one 12-week trial of one strain Same trial only; not replicated or tested with other strains

Questions people ask

What are "GLP-1 supplements"?

It's a marketing term, not a category with a regulatory definition. It gets applied to existing ingredients — most often berberine, fiber blends and specific probiotic strains — because each has some published research, mostly in cells or animals, on GLP-1 secretion. GLP-1 itself is the name of a gut hormone that a class of prescription medicines also targets; the supplement label borrows the name without carrying the same evidence.

Do GLP-1 supplements actually work?

Not in the sense of reliably raising GLP-1 in a person or reproducing what a prescription GLP-1 medicine does. The mechanistic studies behind these ingredients are mostly in cells or animals, and the human trials that exist — which mostly measure body weight rather than GLP-1 itself — disagree with each other, as the reviews above show.

Are GLP-1 supplements safe?

Safety depends on the specific ingredient, not the marketing label. Berberine carries documented gastrointestinal side effects and a broad drug-interaction profile; concentrated fiber supplements can cause gas or bloating if increased too quickly; probiotic strains vary by species. There's no single safety profile for "GLP-1 supplements" as a category, because it isn't one ingredient. Check the specific product's ingredient list against its own safety research, and talk to a doctor or pharmacist if you take any prescription medication.

Do GLP-1 supplements work for weight loss?

The trial evidence above is the direct answer: mixed for berberine across three meta-analyses, inconsistent for fiber, and limited to one small trial for probiotics. None of the three ingredient categories has been shown in human trials to produce weight change comparable to a prescription GLP-1 medicine.

Can I take a "GLP-1 supplement" alongside a prescription GLP-1 medicine?

That depends on the specific supplement and the specific medicine, which isn't something a general article can answer. If you take a prescription GLP-1 medicine, talk to your prescriber before adding berberine, a concentrated fiber supplement, a probiotic, or anything else marketed toward the same goal.

When to talk to a doctor

A product marketed as a "GLP-1 supplement" is not a substitute for a prescription GLP-1 medicine, and nothing here recommends using one instead of medical care for a weight or metabolic condition. If you take a prescription GLP-1 medicine or any other medication, are pregnant or nursing, or manage a chronic health condition, talk to a doctor or pharmacist before adding berberine, a concentrated fiber supplement, or a probiotic — several of the ingredients discussed here interact with medications or carry their own gastrointestinal side effects.

Related reading: is berberine a "natural GLP-1"? what the research does and doesn't show, eating less on a GLP-1 medicine: which nutrients does the research say to watch?, and berberine: what the research does and doesn't show.

Sources

  1. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies Biochemical pharmacology · 2010 · PMID 19945441In rats and a human intestinal cell line in the lab, berberine increased GLP-1 secretion — a preclinical finding, not a measurement in a person.
  2. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways Biochemical pharmacology · 2015 · PMID 26206195A lab study traced part of berberine's GLP-1 effect to a bitter-taste receptor pathway in gut cells — a mechanism study, not a human trial.
  3. Boosting GLP-1 by Natural Products Advances in experimental medicine and biology · 2021 · PMID 34981502A review lists several plant-derived compounds, berberine included, studied for effects on GLP-1 release — mostly preclinical work, not human outcome trials.
  4. The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials Complementary therapies in clinical practice · 2020 · PMID 32379652A meta-analysis of 10 trials found small reductions in BMI and waist circumference from berberine, but no significant change in body weight itself.
  5. Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials Complementary therapies in medicine · 2020 · PMID 32147051A meta-analysis of 12 trials in 849 adults found no significant change in body weight or BMI from berberine, though waist-to-hip ratio fell slightly.
  6. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials Clinical nutrition ESPEN · 2020 · PMID 32690176A 2020 meta-analysis of 12 randomized trials found berberine modestly reduced body weight, BMI and an inflammation marker (CRP), but had no significant effect on the two standard liver-enzyme blood tests, ALT and AST.
  7. Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review Frontiers in endocrinology · 2026 · PMID 42528510A 2026 scoping review of 52 small fiber studies found dextrin-type fibers the most consistent for raising both GLP-1 and satiety, but the evidence is limited by small, short-term trials and doesn't test fiber intake specifically in people on a GLP-1 medicine.
  8. The Effect of Soluble Fiber Dextrin on Subjective and Physiological Markers of Appetite: A Randomized Trial Nutrients · 2020 · PMID 33143121A randomized trial of a soluble fiber dextrin found no effect on GLP-1 or other appetite hormones, and no effect on hunger or how much people ate.
  9. Bifidobacterium Breve BBr60 Improves Obesity Via the Gut Microbiota-Short-Chain Fatty Acid-IL-27/GLP-1 Axis: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial Probiotics and antimicrobial proteins · 2026 · PMID 41455007A 12-week placebo-controlled trial of one specific probiotic strain found GLP-1 and several other gut hormones rose in the probiotic group but not the placebo group, in a single small trial that hasn't been replicated.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.